✦ LIBER ✦

Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia

✍ Scribed by Mike Dennis, Michelle Davies, Stuart Oliver…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I study to assess the safety, ph

✍ Kosuke Tsuboi; Toshiya Yokozawa; Toru Sakura; Takashi Watanabe; Shin Fujisawa; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Phase I/II multicenter study to assess t

✍ H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB

A Phase I study to assess the safety, to

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

418 Phase I, clinical, pharmacokinetic a

✍ E. Raymond; J. Alexandre; T. Besse-Hammer; S. Faivre; B. Longerey; N. Rejeb; A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Determination of tumour hypoxia with [18

✍ P. Mahy; X. Geets; M. Lonneux; P. Levêque; N. Christian; M. De Bast; J. Gillart; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 207 KB

1236 POSTER Phase I Study to Assess the

✍ J. Furuse; Y. Sasaki; T. Okusaka; M. Ikeda; F. Nagashima; Y. Sunakawa; H. Ueno; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB